C. Potzsch et al., ACUTE MYELOMONOCYTIC LEUKEMIA SECONDARY TO SYNCHRONOUS CARCINOMAS OF THE BREAST AND LUNG, AND TO METACHRONOUS RENAL-CELL CARCINOMA, Journal of cancer research and clinical oncology, 123(11-12), 1997, pp. 678-680
We describe a patient in whom synchronous breast cancer and small-cell
lung cancer, and metachronous renal cell carcinoma were diagnosed wit
hin an 11 months period. All three tumors were treated surgically, fol
lowed by administration of tamoxifen, adjuvant chemotherapy with etopo
side (2.8 g/m(2) total) and vindesine, and admin istration of interfer
on alpha and flutamide. The patient developed acute myelomonocytic leu
kemia 26 months after discontinuation of etoposide-containing chemothe
rapy. This pattern of multiple neoplasms fits the wider disease spectr
um associated with germline mutations of the p53 gene; however, analys
is of p53 exons 5-8 did not disclose any sequence abnormalities in thi
s patient. In conclusion, clustering of four (synchronous and metachro
nous) malignancies may on rare occasions occur in an individual patien
t and in the absence of a family history of cancer; the sequence durin
g which treatment of primary malignancies may result in treatment-rela
ted acute myelocytic leukemia is discussed.